Safety and Efficacy of Nusinersen Focusing on Renal and Hematological Parameters in Spinal Muscular Atrophy

ABSTRACT Background Spinal muscular atrophy (SMA) is a motor neuron disease caused by mutations in the SMN1 gene. Nusinersen, an antisense oligonucleotide, has been shown to improve motor function in SMA patients. However, concerns regarding its renal safety remain as previous studies have linked si...

Full description

Saved in:
Bibliographic Details
Main Authors: Hüseyin Bahadır Şenol, Gizem Yıldız, Ayşe İpek Polat, Adem Aydın, Ayşe Semra Hız, Alper Soylu, Uluç Yiş
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.70221
Tags: Add Tag
No Tags, Be the first to tag this record!